Novozymes A/S announced that after 12 years as a member of the Novozymes' Board of Directors, Jørgen Buhl Rasmussen has decided not to seek re-election at the Annual Shareholders' Meeting on March 2, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
425.4 DKK | -0.91% |
|
-0.56% | +14.79% |
06-18 | Transcript : Novozymes A/S - Analyst/Investor Day | |
06-18 | European shares advance ahead of inflation data, more c.bank speakers | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.79% | 29.17B | |
-22.68% | 3.41B | |
+11.09% | 1.76B | |
-22.23% | 554M | |
-32.57% | 361M | |
-81.65% | 216M | |
-9.64% | 116M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novozymes A/S Announces Jørgen Buhl Rasmussen Decides Not to Seek Re-Election as Member of its Board of Directors